No photo of Nikolaos G. Frangogiannis

View Scopus Profile

Nikolaos G. Frangogiannis, M.D.

  • 14586 Citations
  • 65 h-Index
1995 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nikolaos G. Frangogiannis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Myocardial Infarction Medicine & Life Sciences
Myocardium Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Chemokines Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Myofibroblasts Medicine & Life Sciences
Cardiac Myocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2021

Resolution of inflammation in healing myocardial infarcts

Frangogiannis, N. G.

National Institutes of Health

6/1/06 → 5/31/21

Project: Research project

Myocardial Infarction
Inflammation
Interleukin Receptors
Thrombospondin 1
Phosphotransferases

Chemokines in Healing Myocardial Infarcts

Frangogiannis, N. G.

National Institutes of Health

4/1/04 → 1/31/20

Project: Research project

Chemokines
Myocardial Infarction
Monocytes
Chemokine CCL2
Fibroblasts

Publications 1995 2019

Can Myocardial Fibrosis Be Reversed?

Frangogiannis, N. G., May 14 2019, In : Journal of the American College of Cardiology. 73, 18, p. 2283-2285 3 p.

Research output: Contribution to journal › Editorial

Extracellular Matrix
Fibrosis
Fibroblasts
Inflammation

Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart

Huang, S., Chen, B., Su, Y., Alex, L., Humeres, C., Shinde, A. V., Conway, S. J. & Frangogiannis, N. G., Jul 1 2019, In : Journal of Molecular and Cellular Cardiology. 132, p. 84-97 14 p.

Research output: Contribution to journal › Article

Myofibroblasts
Fibroblasts
Integrins
Coronary Occlusion
Myocardial Infarction

Fibroblasts in the Infarcted, Remodeling, and Failing Heart

Humeres, C. & Frangogiannis, N. G., Jun 1 2019, In : JACC: Basic to Translational Science. 4, 3, p. 449-467 19 p.

Research output: Contribution to journal › Review article

Open Access
Fibroblasts
Extracellular Matrix
Fibrosis
Extracellular Matrix Proteins
Cardiac Myocytes
4 Citations (Scopus)

Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities

Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T., Liehn, E. A., Gomes, C. P. C., Schulz, R. & Hausenloy, D. J., Jun 1 2019, In : Cardiovascular research. 115, 7, p. 1117-1130 14 p.

Research output: Contribution to journal › Article

Open Access
Myocardial Infarction
Therapeutics
Anti-Inflammatory Agents
Heart Failure
Lymphocytes

Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation

Chen, B., Huang, S., Su, Y., Wu, Y. J., Hanna, A., Brickshawana, A., Graff, J. & Frangogiannis, N. G., Jun 21 2019, In : Circulation research. 125, 1, p. 55-70 16 p.

Research output: Contribution to journal › Article

Open Access
Phagocytosis
Macrophages
Inflammation
Transforming Growth Factors
Anti-Inflammatory Agents